← Back
$TVTX All transactions

Travere Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$131K

Shares

8,000

Price

$16

Filed

Apr 16

Insider

Name

LYONS GARY A

Title

CIK

0001123343

Roles

Director

Transaction Details

Transaction Date

2026-04-14

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

65,500

Footnotes

This sale was made pursuant to a written plan adopted on November 11, 2025 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 18, 2026. | The stock option is fully vested and exercisable.

Filing Info

Accession No.

0001123343-26-000002

Form Type

4

Issuer CIK

0001438533

LYONS GARY A's History

Date Ticker Type Value
2026-04-14 TVTX M $131K
2026-04-14 TVTX $329K
2026-04-14 TVTX M $0
2025-12-03 NBIX M $718K
2025-12-03 NBIX $2.3M
2025-12-03 NBIX M $0
2025-05-22 NBIX M $0
2025-05-22 NBIX M $0
2025-05-21 NBIX A $0
2025-05-21 NBIX A $0

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15